Articles Related to pathways
Ingredients and Pathways for Sustainable Sheep Breeding Strategies under Low Input Production Systems: The Example of Two Distinct Sheep Breeds
Near East and North Africa have 90 percent of their territory classified as arid or semi-arid rangelands. Increasing importation of animals and animal products are still followed due to an increasing consumers’ demand and poor producing abilities of existing native breeds. The objectives of this paper were to: 1) underline major genetic constraints for improving native sheep breeds productivities
under low input production systems, 2) identify main ingredients and pathways for sustainable sheep breeding strategies under low input production systems.
Cervical Spinal Stimulation at Different Levels Evoked Multisegmental Motor Responses in the Lower Limbs
To report on the effect of electrical stimulation of the cervical spine while recording muscular signal from lower limb
muscles with Cervical Multisegmental Motor Responses (MMR).
Predicting Multi-Drug Inhibition Interactions based on Signaling Networks and Single Drug Dose-Response Information
Inhibiting multiple pathways/targets with combination drug therapies is widely used to maximize therapeutic benefit in many diseases. Therapeutic success can often be improved by concurrently and/or sequentially inhibiting multiple pathways/targets by combining drugs with different mechanisms of action.
The Effect of Interleukin-6-Type Cytokines and Adiponectin on MAPK Activation in the Immortalized Human Chondrocyte C28/I2 Line and Normal Human Chondrocytes
The C28/I2 line of immortalized juvenile human chondrocytes was employed to determine the extent to which recombinant human (rh) interleukin-6 (rhIL-6), the interleukin-6-like cytokine, rh-oncostatin M, and the adipokine, rh-adiponectin, activated extracellularsignal regulated kinase (ERK1/2), p38α mitogen-activated protein kinase (p38α MAPK) and c-Jun-amino-terminal kinase (JNK).
Perspectives and Potential Applications of Ruthenium-Based Nanocarriers for Cancer Therapy
Cancer is a highly heterogeneous disease characterised by continuous uncontrolled growth and expansion of abnormal cells. In general, in tumor cells the signalling pathways regulating cellular processes, as cell growth and division and cell to cellcommunication result strongly altered.
Editorial Board Members Related to pathways

Anthony Joseph Berdis
Assistant Professor
Departments of Chemistry and Biology
Cleveland State University
United States
Departments of Chemistry and Biology
Cleveland State University
United States

Yue Chen
Assistant Professor
Department of Biochemistry, Molecular Biology and Biophysics,
University of Minnesota
United States
Department of Biochemistry, Molecular Biology and Biophysics,
University of Minnesota
United States

Yinghao Wu
Assistant Professor
Department of Systems & Computational Biology
Yeshiva University
United States
Department of Systems & Computational Biology
Yeshiva University
United States

Suman Sirimulla
Assistant Professor
Department of Basic Sciences
St. Louis College of Pharmacy
St. Louis, MO
United States.
Department of Basic Sciences
St. Louis College of Pharmacy
St. Louis, MO
United States.

RICHARD G. MOORE
Professor
Department of Obstetrics and Gynecology
Warren Alpert Medical School
Brown University
United States
Department of Obstetrics and Gynecology
Warren Alpert Medical School
Brown University
United States

Charles J. Malemud
Professor
Department of Medicine and Anatomy
Case Western Reserve University
United States
Department of Medicine and Anatomy
Case Western Reserve University
United States

Eugene S. Kim
Associate Professor
Department of Surgery
University of Southern California
United States
Department of Surgery
University of Southern California
United States

Kam C. Yeung
Associate Professor
Department of Biochemistry & Cancer Biology
University of Toledo College of Medicine
United States
Department of Biochemistry & Cancer Biology
University of Toledo College of Medicine
United States